Cargando…

Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients

BACKGROUND: Eukaryotic translation initiation factor 2B (eIF2B), a guanine nucleotide exchange factor (GEF) and a key regulator of translation initiation under normal and stress conditions, causes an autosomal recessive leukodystrophy of a wide clinical spectrum. EBV-immortalised lymphocytes (EIL) f...

Descripción completa

Detalles Bibliográficos
Autores principales: Horzinski, Laetitia, Kantor, Liraz, Huyghe, Aurélia, Schiffmann, Raphael, Elroy-Stein, Orna, Boespflug-Tanguy, Odile, Fogli, Anne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967530/
https://www.ncbi.nlm.nih.gov/pubmed/20958979
http://dx.doi.org/10.1186/1471-2377-10-94
_version_ 1782189680602644480
author Horzinski, Laetitia
Kantor, Liraz
Huyghe, Aurélia
Schiffmann, Raphael
Elroy-Stein, Orna
Boespflug-Tanguy, Odile
Fogli, Anne
author_facet Horzinski, Laetitia
Kantor, Liraz
Huyghe, Aurélia
Schiffmann, Raphael
Elroy-Stein, Orna
Boespflug-Tanguy, Odile
Fogli, Anne
author_sort Horzinski, Laetitia
collection PubMed
description BACKGROUND: Eukaryotic translation initiation factor 2B (eIF2B), a guanine nucleotide exchange factor (GEF) and a key regulator of translation initiation under normal and stress conditions, causes an autosomal recessive leukodystrophy of a wide clinical spectrum. EBV-immortalised lymphocytes (EIL) from eIF2B-mutated patients exhibit a decrease in eIF2B GEF activity. eIF2B-mutated primary fibroblasts have a hyper-induction of activating transcription factor 4 (ATF4) which is involved in the protective unfolded protein response (UPR), also known as the ER-stress response. We tested the hypothesis that EIL from eIF2B-mutated patients also exhibit a heightened ER-stress response. METHODS: We used thapsigargin as an ER-stress agent and looked at polysomal profiles, rate of protein synthesis, translational activation of ATF4, and transcriptional induction of stress-specific mRNAs (ATF4, CHOP, ASNS, GRP78) in normal and eIF2B-mutated EIL. We also compared the level of stress-specific mRNAs between EIL and primary lymphocytes (PL). RESULTS: Despite the low eIF2B GEF activity in the 12 eIF2B-mutated EIL cell lines tested (range 40-70% of normal), these cell lines did not differ from normal EIL in their ATF4-mediated ER-stress response. The absence of hyper-induction of ATF4-mediated ER-stress response in eIF2B-mutated EIL in contrast to primary fibroblasts is not related to their transformation by EBV. Indeed, PL exhibited a higher induction of the stress-specific mRNAs in comparison to EIL, but no hyper-induction of the UPR was noticed in the eIF2B-mutated cell lines in comparison to controls. CONCLUSIONS: Taken together with work of others, our results demonstrate the absence of a major difference in ER-stress response between controls and eIF2B-mutated cells. Therefore, components of the ER-stress response cannot be used as discriminantory markers in eIF2B-related disorders.
format Text
id pubmed-2967530
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29675302010-11-02 Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients Horzinski, Laetitia Kantor, Liraz Huyghe, Aurélia Schiffmann, Raphael Elroy-Stein, Orna Boespflug-Tanguy, Odile Fogli, Anne BMC Neurol Research Article BACKGROUND: Eukaryotic translation initiation factor 2B (eIF2B), a guanine nucleotide exchange factor (GEF) and a key regulator of translation initiation under normal and stress conditions, causes an autosomal recessive leukodystrophy of a wide clinical spectrum. EBV-immortalised lymphocytes (EIL) from eIF2B-mutated patients exhibit a decrease in eIF2B GEF activity. eIF2B-mutated primary fibroblasts have a hyper-induction of activating transcription factor 4 (ATF4) which is involved in the protective unfolded protein response (UPR), also known as the ER-stress response. We tested the hypothesis that EIL from eIF2B-mutated patients also exhibit a heightened ER-stress response. METHODS: We used thapsigargin as an ER-stress agent and looked at polysomal profiles, rate of protein synthesis, translational activation of ATF4, and transcriptional induction of stress-specific mRNAs (ATF4, CHOP, ASNS, GRP78) in normal and eIF2B-mutated EIL. We also compared the level of stress-specific mRNAs between EIL and primary lymphocytes (PL). RESULTS: Despite the low eIF2B GEF activity in the 12 eIF2B-mutated EIL cell lines tested (range 40-70% of normal), these cell lines did not differ from normal EIL in their ATF4-mediated ER-stress response. The absence of hyper-induction of ATF4-mediated ER-stress response in eIF2B-mutated EIL in contrast to primary fibroblasts is not related to their transformation by EBV. Indeed, PL exhibited a higher induction of the stress-specific mRNAs in comparison to EIL, but no hyper-induction of the UPR was noticed in the eIF2B-mutated cell lines in comparison to controls. CONCLUSIONS: Taken together with work of others, our results demonstrate the absence of a major difference in ER-stress response between controls and eIF2B-mutated cells. Therefore, components of the ER-stress response cannot be used as discriminantory markers in eIF2B-related disorders. BioMed Central 2010-10-19 /pmc/articles/PMC2967530/ /pubmed/20958979 http://dx.doi.org/10.1186/1471-2377-10-94 Text en Copyright ©2010 Horzinski et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Horzinski, Laetitia
Kantor, Liraz
Huyghe, Aurélia
Schiffmann, Raphael
Elroy-Stein, Orna
Boespflug-Tanguy, Odile
Fogli, Anne
Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients
title Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients
title_full Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients
title_fullStr Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients
title_full_unstemmed Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients
title_short Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients
title_sort evaluation of the endoplasmic reticulum-stress response in eif2b-mutated lymphocytes and lymphoblasts from cach/vwm patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967530/
https://www.ncbi.nlm.nih.gov/pubmed/20958979
http://dx.doi.org/10.1186/1471-2377-10-94
work_keys_str_mv AT horzinskilaetitia evaluationoftheendoplasmicreticulumstressresponseineif2bmutatedlymphocytesandlymphoblastsfromcachvwmpatients
AT kantorliraz evaluationoftheendoplasmicreticulumstressresponseineif2bmutatedlymphocytesandlymphoblastsfromcachvwmpatients
AT huygheaurelia evaluationoftheendoplasmicreticulumstressresponseineif2bmutatedlymphocytesandlymphoblastsfromcachvwmpatients
AT schiffmannraphael evaluationoftheendoplasmicreticulumstressresponseineif2bmutatedlymphocytesandlymphoblastsfromcachvwmpatients
AT elroysteinorna evaluationoftheendoplasmicreticulumstressresponseineif2bmutatedlymphocytesandlymphoblastsfromcachvwmpatients
AT boespflugtanguyodile evaluationoftheendoplasmicreticulumstressresponseineif2bmutatedlymphocytesandlymphoblastsfromcachvwmpatients
AT foglianne evaluationoftheendoplasmicreticulumstressresponseineif2bmutatedlymphocytesandlymphoblastsfromcachvwmpatients